Risultati della ricerca - Cheng-Bo Han

Metastatic Breast Cancer Coexisting With HER-2 Amplification and EGFR Exon 19 Deletion Benefits From EGFR-TKI Therapy: A Case Report di Wei Jing, Jie-Tao Ma, Cheng-Bo Han

Testo

Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer: a pooled analysis di Shu-Ling Zhang, Cheng-Bo Han, Li Sun, Le-Tian Huang, Jie-Tao Ma

Testo

Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized contr... di Shu-Ling Zhang, Xiao-Fang Yi, Le-Tian Huang, Li Sun, Jie-Tao Ma, Cheng-Bo Han

Testo

The Optimal First‐Line Therapy for Extensive‐Stage Small‐Cell Lung Cancer Based on Liver Metastasis Status: A Network Meta‐Analysis and Systematic Review di Shu‐Ling Zhang, Jing Yu, Yuan Tian, Jie‐Hui Zhang, Li Sun, Le‐Tian Huang, Jie‐Tao Ma, Cheng‐Bo Han

Testo

Rational application of the first‐line chemotherapy and immune checkpoint inhibitors in advanced nonsmall cell lung cancer: A meta‐analysis di Rui Cao, Jie‐Tao Ma, Shu‐Ling Zhang, Li Sun, Yang Liu, Xiang‐Yan Zhang, Wei Jing, Le‐Tian Huang, Cheng‐Bo Han

Testo

Targeting mitochondria: restoring the antitumor efficacy of exhausted T cells di Mei-Qi Yang, Shu-Ling Zhang, Li Sun, Le-Tian Huang, Jing Yu, Jie-Hui Zhang, Yuan Tian, Cheng-Bo Han, Jie-Tao Ma

Testo

Efficacy and safety of combined immunotherapy and antiangiogenesis with or without chemotherapy for advanced non-small-cell lung cancer: A systematic review and pooled analysis fro... di Ruo-Lin Gao, Jun Song, Li Sun, Zhi-Xuan Wu, Xiao-Fang Yi, Shu-Ling Zhang, Le-Tian Huang, Jie-Tao Ma, Cheng-Bo Han

Testo

Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analys... di Xiao-Fang Yi, Jun Song, Ruo-Lin Gao, Li Sun, Zhi-Xuan Wu, Shu-Ling Zhang, Le-Tian Huang, Jie-Tao Ma, Cheng-Bo Han

Testo

Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case Report di Le-Tian Huang, Jie-Tao Ma, Shu-Ling Zhang, Xiao-Han Li, Li Sun, Wei Jing, Jian-Zhu Zhao, Yan-Ru Wang, Cheng-Bo Han

Testo

Short-term outcomes and safety of radiotherapy for immediate breast reconstruction with autologous flap transfer following breast-conserving surgery di Shu-Ling Zhang, Jun Song, Yan-Ru Wang, Yi-Jia Guo, Jian-Zhu Zhao, Li Sun, Le-Tian Huang, Jie-Tao Ma, Cheng-Bo Han

Testo

Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials di Li Sun, Yi-Jia Guo, Jun Song, Yan-Ru Wang, Shu-Ling Zhang, Le-Tian Huang, Jian-Zhu Zhao, Wei Jing, Cheng-Bo Han, Jie-Tao Ma

Testo

Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cance... di Le-Tian Huang, Rui Cao, Yan-Ru Wang, Li Sun, Xiang-Yan Zhang, Yi-Jia Guo, Jian-Zhu Zhao, Shu-Ling Zhang, Wei Jing, Jun Song, Cheng-Bo Han, Jietao Ma

Testo